A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

Схожие документы

• Multi‐institutional, prospective, randomized, double‐blind, placebo‐controlled phase IIb trial of the tumor lysate, particle‐loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high‐risk melanoma patients: A subgroup analysis
  по: Chick, Robert C., и др.
  Опубликовано: (2021)
• Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
  по: Carpenter, Elizabeth Lee, и др.
  Опубликовано: (2023)
• Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
  по: Adams, Alexandra M., и др.
  Опубликовано: (2022)
• Chemoprevention in familial adenomatous polyposis: past, present and future
  по: Kemp Bohan, Phillip M., и др.
  Опубликовано: (2020)
• Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement
  по: Kemp Bohan, Phillip M., и др.
  Опубликовано: (2020)